PHOSPHO-SPECIFIC ANTIBODY FOR CaM KINASE II
|
UCLA Technology Available For Licensing |
BACKGROUND:
Calcium/calmodulin-dependent protein kinases (CaM kinases) are a family of proteins involved in many biological processes throughout the human body. These processes include metabolism, electrolyte regulation, gene expression, and many brain functions critical to learning and memory. Calmodulin is a protein that, when bound to calcium, causes activation of CaM kinase. However, when the calcium/calmodulin complex falls off an already activated CaM kinase, a phenomenon known as inhibitory phosphorylation occurs. Phosphates become attached to specific amino acids on CaM kinase, leading to decreased sensitivity to the calcium/calmodulin signal and an overall inhibition of the kinase. This inhibition has been shown to play an important role in the regulation of CaM Kinase II, a protein found in the brain which is essential to learning and memory.
INNOVATION:
UCLA researchers have developed a polyclonal antibody that recognizes the phosphorylated amino acid sequence involved in the inhibition of CaM kinase II. This is distinct from previous antibodies specific only for the phosphorylated sequence involved in the activation process. Research into inhibitory phosphorylation has yielded potential therapeutic targets in certain forms of mental retardation.
POTENTIAL APPLICATIONS
- Can be used in a wide variety of immunological approaches to quantitate the level of phosphorylation and inhibition in
ADVANTAGES
- This is the only known antibody specific for this particular inhibitory site
- This antibody is tested and ready to be used as a research reagent
Related Papers (Selected)
Elgersma Y, Fedorov NB, Ikonen S, Choi ES, Elgersma M, Carvalho KP, Silva AJ. "Inhibitory autophosphorylation of CaMKII controls PSD Association, plasticity, and learning". Neuron 2002; 36(3): 493-505
2. Weeber EJ, Jiang YH, Elgersma Y, Varga AW, Carrasquillo Y, Brown SE, Christian JM, Mirnikjoo B, Silva AJ, Beaudet AL, Sweat JD. "Derangements of hippocampal calcium/calmodulin-dependent protein kinase II in a mouse model for Angelman mental retardation syndrome" J of Neurosci 2003; 23(7): 2634-44.
Reference: UCLA Case No. 2003-450
For additional technical details and current licensing
availability,
please contact the following UCLA office:
UCLA Office of Intellectual Property
11000 Kinross Avenue, Suite #200
Los Angeles, CA 90095-7231
Tel: 310-794-0558 Fax: 310-794-0638
email: ncd@research.ucla.edu
|
NCD URL: http://www.research.ucla.edu/tech/ucla03-450.htm
|
UCLA Technologies Available for
Licensing
http://www.research.ucla.edu/oipa/industry
Copyright © 2007 The Regents of the
University of California.
keywords: therapeutics
uclancd ucla technologies intellectual property patents technology transfer invention business card